{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:35:34Z","timestamp":1782801334096,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,17]]},"DOI":"10.7759\/cureus.54344","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T10:19:07Z","timestamp":1708165147000},"source":"Crossref","is-referenced-by-count":2,"title":["An Evaluation of Treatment Outcomes and Associated Factors in Nasopharyngeal Cancer Patients at a Tertiary Cancer Center in the United Arab Emirates"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Bin Sumaida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandan M","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain A","family":"Aby Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalifa","family":"AlKaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Balaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Anatomy, Head and Neck, Nasopharynx","author":"Mankowski NL","year":"2024","unstructured":"Mankowski NL, Bordoni B. Anatomy, Head and Neck, Nasopharynx. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-936x(79)90056-0","article-title":"CT anatomy of the nasopharynx, nasal cavity, paranasal sinuses, and infratemporal fossa","volume":"3","author":"Nicholson RL","year":"1979","unstructured":"Nicholson RL, Kreel L. CT anatomy of the nasopharynx, nasal cavity, paranasal sinuses, and infratemporal fossa. J Comput Tomogr. 1979, 3:13-23. 10.1016\/0149-936x(79)90056-0","journal-title":"J Comput Tomogr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang ET","year":"2006","unstructured":"Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15:1765-77. 10.1158\/1055-9965.EPI-06-0353","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-023-01438-x","article-title":"Comprehensive analysis of circular RNAs in nasopharyngeal cancer","volume":"45","author":"Zhu SY","year":"2023","unstructured":"Zhu SY, Wang XY, Xie H, Liu LZ. Comprehensive analysis of circular RNAs in nasopharyngeal cancer. Genes Genomics. 2023, 45:1339-46. 10.1007\/s13258-023-01438-x","journal-title":"Genes Genomics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102892","article-title":"Global frequency and distribution of head and neck cancer in pediatrics, a systematic review","volume":"148","author":"Arboleda LP","year":"2020","unstructured":"Arboleda LP, de Mendon\u00e7a RM, Lopez EE, et al.. Global frequency and distribution of head and neck cancer in pediatrics, a systematic review. Crit Rev Oncol Hematol. 2020, 148:102892. 10.1016\/j.critrevonc.2020.102892","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215109005623","article-title":"Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review","volume":"123","author":"Yu WM","year":"2009","unstructured":"Yu WM, Hussain SS. Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review. J Laryngol Otol. 2009, 123:1067-74. 10.1017\/S0022215109005623","journal-title":"J Laryngol Otol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.10.4447","article-title":"Epidemiology of nasopharyngeal cancers in Iran: a 6-year report","volume":"16","author":"Safavi A","year":"2015","unstructured":"Safavi A, Raad N, Raad N, Ghorbani J. Epidemiology of nasopharyngeal cancers in Iran: a 6-year report. Asian Pac J Cancer Prev. 2015, 16:4447-50. 10.7314\/apjcp.2015.16.10.4447","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref8","unstructured":"Global Cancer Observatory. Cancer Today. (2024). Accessed: February 2, 2024: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/784-united-arab-emirates-fact-sheet.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02814-x","article-title":"SEOM-TTCC clinical guideline in nasopharynx cancer (2021)","volume":"24","author":"Rueda Dom\u00ednguez A","year":"2022","unstructured":"Rueda Dom\u00ednguez A, Cirauqui B, Garc\u00eda Casta\u00f1o A, et al.. SEOM-TTCC clinical guideline in nasopharynx cancer (2021). Clin Transl Oncol. 2022, 24:670-80. 10.1007\/s12094-022-02814-x","journal-title":"Clin Transl Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1702","article-title":"The evolving epidemiology of nasopharyngeal carcinoma","volume":"30","author":"Chang ET","year":"2021","unstructured":"Chang ET, Ye W, Zeng YX, Adami HO. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2021, 30:1035-47. 10.1158\/1055-9965.EPI-20-1702","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-54088-3_41","article-title":"Nasopharyngeal cancer","author":"Larem A","year":"2021","unstructured":"Larem A, Al Duhirat E, Omer H. Nasopharyngeal cancer. Textbook of Clinical Otolaryngology. Al-Qahtani A, Haidar H, Larem A, (ed): Springer,  Cham, Switzerland; 2021. 2:479-85. 10.1007\/978-3-030-54088-3_41"},{"key":"ref13","article-title":"Nasopharyngeal Carcinoma (NPC, Lymphoepithelioma)","author":"Almomani MH","year":"2024","unstructured":"Almomani MH, Zulfiqar H, Nagalli S. Nasopharyngeal Carcinoma (NPC, Lymphoepithelioma). StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry JA","year":"2016","unstructured":"Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, Valsamakis A. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016, 127:2007-17. 10.1182\/blood-2015-09-672030","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.05.022","article-title":"A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma","volume":"153","author":"Lee AW","year":"2021","unstructured":"Lee AW, Lee VH, Ng WT, et al.. A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma. Eur J Cancer. 2021, 153:109-22. 10.1016\/j.ejca.2021.05.022","journal-title":"Eur J Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/tri.14107","article-title":"EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review","volume":"34","author":"Liu JY","year":"2021","unstructured":"Liu JY, Zhang JM, Zhan HS, Sun LY, Wei L. EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review. Transpl Int. 2021, 34:2483-93. 10.1111\/tri.14107","journal-title":"Transpl Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092122","article-title":"Prognostic biomarkers for survival in nasopharyngeal carcinoma: a systematic review of the literature","volume":"14","author":"Islam KA","year":"2022","unstructured":"Islam KA, Chow LK, Kam NW, et al.. Prognostic biomarkers for survival in nasopharyngeal carcinoma: a systematic review of the literature. Cancers (Basel). 2022, 14:4-6. 10.3390\/cancers14092122","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2012.01.009","article-title":"Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review","volume":"22","author":"Jia WH","year":"2012","unstructured":"Jia WH, Qin HD. Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review. Semin Cancer Biol. 2012, 22:117-26. 10.1016\/j.semcancer.2012.01.009","journal-title":"Semin Cancer Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2832","article-title":"Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis","volume":"9","author":"Hsu WL","year":"2020","unstructured":"Hsu WL, Chien YC, Huang YT, et al.. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis. Cancer Med. 2020, 9:1867-76. 10.1002\/cam4.2832","journal-title":"Cancer Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1902-9","article-title":"Smoking and nasopharyngeal carcinoma mortality: a cohort study of 101,823 adults in Guangzhou, China","volume":"15","author":"Lin JH","year":"2015","unstructured":"Lin JH, Jiang CQ, Ho SY, et al.. Smoking and nasopharyngeal carcinoma mortality: a cohort study of 101,823 adults in Guangzhou, China. BMC Cancer. 2015, 15:906. 10.1186\/s12885-015-1902-9","journal-title":"BMC Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"6","author":"Chen YP","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019, 6:64-80. 10.1016\/S0140-6736(19)30956-0","journal-title":"Lancet"},{"key":"ref22","article-title":"Nasopharyngeal Cancer","author":"Sinha S","year":"2024","unstructured":"Sinha S, Winters R, Gajra A. Nasopharyngeal Cancer. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626145","article-title":"The most efficacious induction chemotherapy regimen for locoregionally advanced nasopharyngeal carcinoma: a network meta-analysis","volume":"11","author":"Choi HC","year":"2021","unstructured":"Choi HC, Chan SK, Lam KO, et al.. The most efficacious induction chemotherapy regimen for locoregionally advanced nasopharyngeal carcinoma: a network meta-analysis. Front Oncol. 2021, 11:626145. 10.3389\/fonc.2021.626145","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.314.7374","article-title":"Is gemcitabine and cisplatin induction chemotherapy superior in locoregionally advanced nasopharyngeal carcinoma?","volume":"31","author":"Zheng W","year":"2015","unstructured":"Zheng W, Qiu S, Huang L, Pan J. Is gemcitabine and cisplatin induction chemotherapy superior in locoregionally advanced nasopharyngeal carcinoma?. Pak J Med Sci. 2015, 31:781-6. 10.12669\/pjms.314.7374","journal-title":"Pak J Med Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken JB","year":"2007","unstructured":"Vermorken JB, Remenar E, van Herpen C, et al.. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007, 357:1695-704. 10.1056\/NEJMoa071028","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70279-5","article-title":"Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial","volume":"12","author":"Lorch JH","year":"2011","unstructured":"Lorch JH, Goloubeva O, Haddad RI, et al.. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011, 12:153-9. 10.1016\/S1470-2045(10)70279-5","journal-title":"Lancet Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020443","article-title":"Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma","volume":"99","author":"Chen J","year":"2020","unstructured":"Chen J, Liu T, Sun Q, Jin T. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma. Medicine (Baltimore). 2020, 99:e20443. 10.1097\/MD.0000000000020443","journal-title":"Medicine (Baltimore)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/pro6.1123","article-title":"Guidelines for radiotherapy of nasopharyngeal carcinoma","volume":"5","author":"Wang R","year":"2021","unstructured":"Wang R, Kang M. Guidelines for radiotherapy of nasopharyngeal carcinoma. Prec Radiat Oncol. 2021, 5:122-59. 10.1002\/pro6.1123","journal-title":"Prec Radiat Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49882","article-title":"Understanding the radiation dose variability in nasopharyngeal cancer: an organs-at-risk approach","volume":"15","author":"Bin Sumaida A","year":"2023","unstructured":"Bin Sumaida A, Shanbhag NM, Balaraj KS, et al.. Understanding the radiation dose variability in nasopharyngeal cancer: an organs-at-risk approach. Cureus. 2023, 15:e49882. 10.7759\/cureus.49882","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015951","article-title":"Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: a meta-analysis","volume":"98","author":"Luo MS","year":"2019","unstructured":"Luo MS, Huang GJ, Liu HB. Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: a meta-analysis. Medicine (Baltimore). 2019, 98:e15951. 10.1097\/MD.0000000000015951","journal-title":"Medicine (Baltimore)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.1777","article-title":"Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study","volume":"21","author":"Liang Z","year":"2014","unstructured":"Liang Z, Zhu X, Li L, et al.. Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study. Curr Oncol. 2014, 21:e408-17. 10.3747\/co.21.1777","journal-title":"Curr Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231155721","article-title":"Impact of radiotherapy combined with chemotherapy on long-term outcomes of patients with recurrent nasopharyngeal carcinoma","volume":"22","author":"Li Y","year":"2023","unstructured":"Li Y, Liu W, Xu Y, et al.. Impact of radiotherapy combined with chemotherapy on long-term outcomes of patients with recurrent nasopharyngeal carcinoma. Technol Cancer Res Treat. 2023, 22:15330338231155721. 10.1177\/15330338231155721","journal-title":"Technol Cancer Res Treat"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2022.42.267.33358","article-title":"Stereotactic radiosurgery with Cyberknife(\u00ae): first case in the United Arab Emirates (a case report)","volume":"42","author":"Shanbhag NM","year":"2022","unstructured":"Shanbhag NM, Antypas C, Msaddi AK, Singh T, Murphy SC, Baguitan B. Stereotactic radiosurgery with Cyberknife(\u00ae): first case in the United Arab Emirates (a case report). Pan Afr Med J. 2022, 42:267. 10.11604\/pamj.2022.42.267.33358","journal-title":"Pan Afr Med J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52143","article-title":"Initial experience with 6d skull tracking and intrafractional motion monitoring in the United Arab Emirates' first CyberKnife\u00ae radiosurgery center","volume":"16","author":"Singh T","year":"2024","unstructured":"Singh T, Singh D, Murphy SC, Bin Sumaida A, Shanbhag NM. Initial experience with 6d skull tracking and intrafractional motion monitoring in the United Arab Emirates' first CyberKnife\u00ae radiosurgery center. Cureus. 2024, 16:e52143. 10.7759\/cureus.52143","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21821","article-title":"Meningioma treated with hypofractionated stereotactic radiotherapy using CyberKnife\u00ae: first in the United Arab Emirates","volume":"14","author":"Shanbhag NM","year":"2022","unstructured":"Shanbhag NM, Antypas C, Msaddi AK, Murphy SC, Singh TT. Meningioma treated with hypofractionated stereotactic radiotherapy using CyberKnife\u00ae: first in the United Arab Emirates. Cureus. 2022, 14:e21821. 10.7759\/cureus.21821","journal-title":"Cureus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-20-00082.1","article-title":"A systematic review of proton therapy for the management of nasopharyngeal cancer","volume":"8","author":"Lee A","year":"2021","unstructured":"Lee A, Kitpanit S, Chilov M, Langendijk JA, Lu J, Lee NY. A systematic review of proton therapy for the management of nasopharyngeal cancer. Int J Part Ther. 2021, 8:119-30. 10.14338\/IJPT-20-00082.1","journal-title":"Int J Part Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164177-an-evaluation-of-treatment-outcomes-and-associated-factors-in-nasopharyngeal-cancer-patients-at-a-tertiary-cancer-center-in-the-united-arab-emirates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T10:19:11Z","timestamp":1708165151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164177-an-evaluation-of-treatment-outcomes-and-associated-factors-in-nasopharyngeal-cancer-patients-at-a-tertiary-cancer-center-in-the-united-arab-emirates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,17]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.54344","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,17]]}}}